| Elisa Bomgaars, MD | |
|
5810 W Beverly Ln, Glendale, AZ 85306-1800 | |
| (623) 312-3000 | |
| (623) 312-3060 |
| Full Name | Elisa Bomgaars |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 27 Years |
| Location | 5810 W Beverly Ln, Glendale, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841220225 | NPI | - | NPPES |
| 835216 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 47975 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Banner Thunderbird Medical Center | Glendale, AZ | Hospital |
| Honorhealth Deer Valley Medical Center | Phoenix, AZ | Hospital |
| Arrowhead Hospital | Glendale, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ironwood Physicians Pc | 3577454842 | 101 |
News Archive
A larger-than-life model of the human central nervous system including the brain and spinal cord, which will allow oncologists and neurosurgeons to target tumours more effectively, will be among a range of student projects on display at an event at The University of Nottingham this week.
The first randomized, placebo-controlled U.S. clinical trial to assess the use of bone marrow-derived mononuclear cells (BMC) in patients after a ST-elevation myocardial infarction (STEMI; severe heart attack) demonstrated a strong safety profile for this cell therapy, based on phase 1 results published in the September issue of the American Heart Journal.
A research team including NIBIB-funded scientists has developed an improved MRI technique with the potential to provide more precise and effective treatment for prostate cancer. The imaging technique improves upon standard MRI to obtain clearer images of the extent of the tumor and its exact location. A sharper image can provide more accurate biopsies, enable better treatment planning, and help surgeons pinpoint the tumor while sparing surrounding healthy tissue.
A new chemotherapy pill is showing early success in treating people with stubborn lymphomas, according to scientists at the University of Rochester Medical Center. Doctors reported that the drug is halting disease in nearly half of the patients with chronic lymphocytic leukemia, and in patients with more aggressive lymphoma as well.
A new app to help people make positive changes to their diet and physical activity will launch next year, the government has announced today.
› Verified 2 days ago
| Entity Name | Ironwood Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740269299 PECOS PAC ID: 3577454842 Enrollment ID: O20040324000807 |
News Archive
A larger-than-life model of the human central nervous system including the brain and spinal cord, which will allow oncologists and neurosurgeons to target tumours more effectively, will be among a range of student projects on display at an event at The University of Nottingham this week.
The first randomized, placebo-controlled U.S. clinical trial to assess the use of bone marrow-derived mononuclear cells (BMC) in patients after a ST-elevation myocardial infarction (STEMI; severe heart attack) demonstrated a strong safety profile for this cell therapy, based on phase 1 results published in the September issue of the American Heart Journal.
A research team including NIBIB-funded scientists has developed an improved MRI technique with the potential to provide more precise and effective treatment for prostate cancer. The imaging technique improves upon standard MRI to obtain clearer images of the extent of the tumor and its exact location. A sharper image can provide more accurate biopsies, enable better treatment planning, and help surgeons pinpoint the tumor while sparing surrounding healthy tissue.
A new chemotherapy pill is showing early success in treating people with stubborn lymphomas, according to scientists at the University of Rochester Medical Center. Doctors reported that the drug is halting disease in nearly half of the patients with chronic lymphocytic leukemia, and in patients with more aggressive lymphoma as well.
A new app to help people make positive changes to their diet and physical activity will launch next year, the government has announced today.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elisa Bomgaars, MD Po Box 6423, Chandler, AZ 85246-6423 Ph: () - | Elisa Bomgaars, MD 5810 W Beverly Ln, Glendale, AZ 85306-1800 Ph: (623) 312-3000 |
News Archive
A larger-than-life model of the human central nervous system including the brain and spinal cord, which will allow oncologists and neurosurgeons to target tumours more effectively, will be among a range of student projects on display at an event at The University of Nottingham this week.
The first randomized, placebo-controlled U.S. clinical trial to assess the use of bone marrow-derived mononuclear cells (BMC) in patients after a ST-elevation myocardial infarction (STEMI; severe heart attack) demonstrated a strong safety profile for this cell therapy, based on phase 1 results published in the September issue of the American Heart Journal.
A research team including NIBIB-funded scientists has developed an improved MRI technique with the potential to provide more precise and effective treatment for prostate cancer. The imaging technique improves upon standard MRI to obtain clearer images of the extent of the tumor and its exact location. A sharper image can provide more accurate biopsies, enable better treatment planning, and help surgeons pinpoint the tumor while sparing surrounding healthy tissue.
A new chemotherapy pill is showing early success in treating people with stubborn lymphomas, according to scientists at the University of Rochester Medical Center. Doctors reported that the drug is halting disease in nearly half of the patients with chronic lymphocytic leukemia, and in patients with more aggressive lymphoma as well.
A new app to help people make positive changes to their diet and physical activity will launch next year, the government has announced today.
› Verified 2 days ago
Dr. Stephanie D Martinez Hawthorne, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 7701 W Aspera Blvd, Glendale, AZ 85308 Phone: 623-248-2109 Fax: 623-707-4893 | |
Dr. Sanjay B Kulkarni, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5555 W. Thunderbird, Banner Thunderbird Medical Center, Glendale, AZ 85306 Phone: 602-865-2627 Fax: 602-865-2632 | |
Arya John Nikamal, D.O. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 5555 W Thunderbird Rd, Glendale, AZ 85306 Phone: 602-865-5555 | |
David Warfield, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5601 W Eugie Ave Ste 203, Glendale, AZ 85304 Phone: 602-633-3833 Fax: 602-633-3834 | |
Anne Margaret Floyd, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5620 W Thunderbird Rd Ste H3, Glendale, AZ 85306 Phone: 480-994-5012 | |
Dr. Karen Brenda Alonso, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5555 W. Thunderbird, Banner Thunderbird Medical Center, Glendale, AZ 85306 Phone: 602-865-2627 Fax: 602-865-2632 | |
Dr. Abrar U Khan, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5555 W Thunderbird, Banner Thunderbird Medical Center, Glendale, AZ 85306 Phone: 602-865-2627 Fax: 602-865-2631 |